NEW YORK (GenomeWeb News) – Anagnostics today announced that genXpress Service & Vertriebs has started distributing its pharmacogenetics products in Austria.

Financial and other terms were not disclosed.

Based near Vienna, genXpress is a supplier of molecular biology products in Austria.

In February, Anagnostics, which develops tests and systems aimed at the pharmaceutical and clinical diagnostics spaces, reached an agreement with Ramcon A/S to sell its hybcell drug screening tests and pharmacogenetics tests in parts of Scandinavia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.